|
FDA Advisary Panel Just OK'd New Prostate Drug
By vote of 17-0, the panel approved the safety of the new prostate drug. By vote of 14-3, the panel approved the efficacy of the drug, The drug maker is DNDN (the stock symbol) The experimental drug works on an entirely new mechanism. You will read the news in tomorrow's paper.
__________________
Ann
Stage 1 dx Sept 05
ER/PR positive HER2 +++ Grade 3
Invasive carcinoma 1 cm, no node involvement
Mastec Sept 05
Annual scans all negative, Oct 06
Postmenopause. Arimidex only since Sept 06, bone or muscle ache after 3 month
Off Arimidex, change to Femara 1/12-07, ache stopped
Sept 07 all tests negative, pass 2 year mark
Feb 08 continue doing well.
Sep 09 four year NED still on Femara.
|
Threaded Mode